Patents by Inventor Daniel Marquess

Daniel Marquess has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cross-linked glycopeptide-cephalosporin antibiotics
    Patent number: 7067482
    Abstract: This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
    Type: Grant
    Filed: July 9, 2004
    Date of Patent: June 27, 2006
    Assignee: Theravance, Inc.
    Inventors: Paul R. Fatheree, Martin S. Linsell, Daniel Marquess, Sean G. Trapp, Edmund J. Moran, James B. Aggen
  • Cross-linked glycopeptide-cephalosporin antibiotics
    Patent number: 7067481
    Abstract: This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
    Type: Grant
    Filed: May 21, 2004
    Date of Patent: June 27, 2006
    Assignee: Theravance, Inc.
    Inventors: Paul R. Fatheree, Martin S. Linsell, Daniel Marquess, Daniel D. Long, Jason P. Chinn, Matthew B. Nodwell, Edmund J. Moran, James B. Aggen
  • Indazole-carboxamide compounds
    Publication number: 20060135764
    Abstract: The invention provides novel indazole-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: December 21, 2005
    Publication date: June 22, 2006
    Inventors: Paul Fatheree, Roland Gendron, Adam Goldblum, Daniel Long, Daniel Marquess, S. Derek Turner, Seok-Ki Choi
  • Cross-linked glycopeptide-cephalosporin antibiotics
    Publication number: 20060128612
    Abstract: This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: January 30, 2006
    Publication date: June 15, 2006
    Inventors: Paul Fatheree, Martin Linsell, Daniel Marquess, Daniel Long, Jason Chinn, Matthew Nodwell, Edmund Moran, James Aggen
  • 5-HT4 receptor agonist compounds
    Publication number: 20060100236
    Abstract: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: November 4, 2005
    Publication date: May 11, 2006
    Applicant: THERAVANCE, INC.
    Inventors: Seok-Ki Choi, Paul Fatheree, Adam Goldblum, Lan Jiang, Daniel Long, Daniel Marquess, S. Turner
  • Quinolinone-carboxamide compounds
    Publication number: 20060100426
    Abstract: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: November 4, 2005
    Publication date: May 11, 2006
    Inventors: Seok-Ki Choi, Paul Fatheree, Roland Gendron, Adam Goldblum, Lan Jiang, Daniel Long, Daniel Marquess
  • Cross-linked glycopeptide-cephalosporin antibiotics
    Patent number: 6995138
    Abstract: This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
    Type: Grant
    Filed: October 18, 2004
    Date of Patent: February 7, 2006
    Assignee: Theravance, Inc.
    Inventors: Daniel Marquess, Martin S. Linsell, S. Derek Turner, Sean G. Trapp, Daniel D. Long, Paul R. Fatheree
  • Cross-linked glycopeptide-cephalosporin antibiotics
    Publication number: 20060025332
    Abstract: This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: September 22, 2005
    Publication date: February 2, 2006
    Inventors: Daniel Marquess, Martin Linsell, Paul Fatheree, Michael Leadbetter
  • Cross-linked glycopeptide-cephalosporin antibiotics
    Patent number: 6974797
    Abstract: This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
    Type: Grant
    Filed: October 11, 2002
    Date of Patent: December 13, 2005
    Assignee: Theravance, Inc.
    Inventors: Paul R. Fatheree, Martin S. Linsell, Daniel D. Long, Daniel Marquess, Edmund J. Moran, Matthew B. Nodwell, S. Derek Turner, James Aggen
  • Cross-linked glycopeptide - cephalosporin antibiotics
    Publication number: 20050239691
    Abstract: This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: June 30, 2005
    Publication date: October 27, 2005
    Inventors: Paul Fatheree, Martin Linsell, Daniel Long, Daniel Marquess, Edmund Moran, Matthew Nodwell, S. Turner, James Aggen
  • Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
    Publication number: 20050228014
    Abstract: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: April 6, 2005
    Publication date: October 13, 2005
    Inventors: Daniel Marquess, Paul Fatheree, S. Derek Turner, Daniel Long, Seok-Ki Choi, Adam Goldblum, Daniel Genov
  • CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS
    Publication number: 20050209132
    Abstract: This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: October 18, 2004
    Publication date: September 22, 2005
    Inventors: Daniel Marquess, Martin Linsell, S. Turner, Sean Trapp, Daniel Long, Paul Fatheree
  • Indazole-carboxamide compounds as 5-HT4 receptor agonists
    Publication number: 20050197335
    Abstract: The invention provides novel indazole-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: February 17, 2005
    Publication date: September 8, 2005
    Inventors: Daniel Marquess, Seok-Ki Choi, Paul Fatheree, Roland Gendron, Adam Goldblum, Daniel Long, S. Derek Turner, Jyanwei Liu
  • Sodium channel modulators
    Publication number: 20050130966
    Abstract: The invention provides sodium channel modulating compounds which are useful for treating diseases or conditions associated with sodium channel activity, such as neuropathic pain. The invention also provides pharmaceutical compositions comprising a compound of the present invention, as well as therapeutic methods comprising administering such a compound or salt to a mammal (e.g. a human).
    Type: Application
    Filed: February 4, 2005
    Publication date: June 16, 2005
    Inventors: Seok-Ki Choi, Paul Fatheree, David Green, Daniel Marquess
  • Cross-linked glycopeptide-cephalosporin antibiotics
    Patent number: 6878686
    Abstract: This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
    Type: Grant
    Filed: May 23, 2003
    Date of Patent: April 12, 2005
    Assignee: Theravance, Inc.
    Inventors: Daniel Marquess, Martin S. Linsell, S. Derek Turner, Sean G. Trapp, Daniel D. Long, Paul R. Fatheree
  • Sodium channel modulators
    Patent number: 6872741
    Abstract: The invention provides sodium channel modulating compounds which are useful for treating diseases or conditions associated with sodium channel activity, such as neuropathic pain. The invention also provides pharmaceutical compositions comprising a compound of the present invention, as well as therapeutic methods comprising administering such a compound or salt to a mammal (e.g. a human).
    Type: Grant
    Filed: September 11, 2003
    Date of Patent: March 29, 2005
    Assignee: Theravance, Inc.
    Inventors: Seok-Ki Choi, Paul R. Fatheree, David C. Green, Daniel Marquess
  • Cross-linked glycopeptide-cephalosporin antibiotics
    Publication number: 20050026818
    Abstract: This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: July 9, 2004
    Publication date: February 3, 2005
    Inventors: Paul Fatheree, Martin Linsell, Daniel Marquess, Sean Trapp, Edmund Moran, James Aggen
  • Cross-linked glycopeptide-cephalosporin antibiotics
    Publication number: 20040266666
    Abstract: This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: May 21, 2004
    Publication date: December 30, 2004
    Inventors: Paul R. Fatheree, Martin S. Linsell, Daniel Marquess, Daniel D. Long, Jason P. Chinn, Matthew B. Nodwell, Edmund J. Moran, James B. Aggen
  • Sodium channel modulators
    Publication number: 20040204460
    Abstract: The invention provides sodium channel modulating compounds of formula I: 1
    Type: Application
    Filed: April 15, 2004
    Publication date: October 14, 2004
    Inventors: Jason P. Chinn, Seok-Ki Choi, Paul R. Fatheree, Daniel Marquess, S. Derek Turner
  • Sodium channel modulators
    Patent number: 6756400
    Abstract: The invention provides sodium channel modulating compounds of formula I: wherein X, Y, Q, R1, w, and R2 have any of the values defined in the specification, and salts thereof, which are useful for treating diseases or conditions associated with sodium channel activity, such as neuropathic pain. The invention also provides pharmaceutical compositions comprising a compound of formula (I) or a salt thereof, as well as therapeutic methods comprising administering such a compound or salt to a mammal (e.g. a human).
    Type: Grant
    Filed: August 30, 2001
    Date of Patent: June 29, 2004
    Assignee: Theravance, Inc.
    Inventors: Jason P. Chinn, Seok-Ki Choi, Paul R. Fatheree, Daniel Marquess, S. Derek Turner